Demystification of microbial behaviour in mixed biofilms could have a major impact on our understanding of infectious diseases. The objectives of this study were to evaluate in vitro the interactions of six different Candida species and a Gram-negative coliform, Escherichia coli, in dual-species biofilms, and to assess the effect of E. coli LPS on Candida biofilm formation. A single isolate of E. coli ATCC 25922 and six different species of Candida, Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258, Candida tropicalis ATCC 13803, Candida parapsilosis ATCC 22019 and Candida dubliniensis MYA-646, were studied using a standard biofilm assay. Each Candida species was co-cultured with E. coli on a polystyrene surface and biofilm formation was quantified by a c.f.u. assay. The biofilm was then analysed by Live/Dead staining and fluorescence microscopy (confocal laser-scanning microscopy, CLSM), whilst scanning electron microscopy (SEM) was employed to visualize the biofilm architecture. The effect of E. coli LPS on Candida biofilm cell activity at defined time intervals was assessed with an XTT reduction assay. A significant quantitative reduction in c.f.u. counts of C. tropicalis (after 90 min), C. parapsilosis (after 90 min and 24 h), C. krusei (after 24 h) and C. dubliniensis (after 24 and 48 h) was noted on incubation with E. coli in comparison with their monospecies biofilm counterparts (P <0.05). On the other hand, a simultaneous and significant reduction in E. coli cell numbers occurred on co-culture with C. albicans (after 90 min), and an elevation of E. coli cell numbers followed co-culture with C. tropicalis (after 24 h) and C. dubliniensis (after 24 h and 48 h) (P <0.05). All quantitative findings were confirmed by SEM and CLSM analyses. By SEM observation, dual-species biofilms demonstrated scanty architecture with reduced visible cell counts at all stages of biofilm development, despite profuse growth and dense colonization in their single-species counterparts. Significantly elevated metabolic activity, as assessed by XTT readings, was observed in E. coli LPS-treated C. tropicalis and C. parapsilosis biofilms (after 48 h), whilst this had the opposite effect for C. dubliniensis (after 24 h) (P <0.05). These data indicate that E. coli and Candida species in a mixed-species environment mutually modulate biofilm development, both quantitatively and qualitatively, and that E. coli LPS appears to be a key component in mediating these outcomes.
AkagawaG.,
AbeS.,
YamaguchiH.1995; Mortality of Candida albicans -infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. J Infect Dis 171:1539–1544[CrossRef]
BanerjeeS. N.,
EmoriT. G.,
CulverD. H.,
GaynesR. P.,
JarvisW. R.,
HoranT.,
EdwardsJ. R.,
TolsonJ.,
HendersonT.,
MartoneW. J.1991; Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med 91:86S–89S
DahindenC.,
GalanosC.,
FehrJ.1983; Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. J Immunol 130:857–862
GilbertH. M.,
PetersE. D.,
LangS. J.,
HartmanB. J.1996; Successful treatment of fungal prosthetic valve endocarditis: case report and review. Clin Infect Dis 22:348–354[CrossRef]
HenricksP. A.,
van der TolM. E.,
ThyssenR. M.,
van AsbeckB. S.,
VerhoefJ.1983; Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes. Infect Immun 41:294–301
Henry-StanleyM. J.,
HessD. J.,
EricksonE. A.,
GarniR. M.,
WellsC. L.2003; Effect of lipopolysaccharide on virulence of intestinal Candida albicans
. J Surg Res 113:42–49[CrossRef]
JinY.,
ZhangT.,
SamaranayakeY. H.,
FangH. H.,
YipH. K.,
SamaranayakeL. P.2005; The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 159:353–360[CrossRef]
JonesR. N.,
MarshallS. A.,
PfallerM. A.,
WilkeW. W.,
HollisR. J.,
ErwinM. E.,
EdmondM. B.,
WenzelR. P.1997; Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 29:95–102[CrossRef]
NairR. G.,
SamaranayakeL. P.1996a; The effect of oral commensal bacteria on candidal adhesion to denture acrylic surfaces. An in vitro study. APMIS 104:339–349[CrossRef]
NairR. G.,
SamaranayakeL. P.1996b; The effect of oral commensal bacteria on candidal adhesion to human buccal epithelial cells in vitro
. J Med Microbiol 45:179–185[CrossRef]
PalmaC.,
CassoneA.,
SerbousekD.,
PearsonC. A.,
DjeuJ. Y.1992; Lactoferrin release and interleukin-1, interleukin-6, and tumor necrosis factor production by human polymorphonuclear cells stimulated by various lipopolysaccharides: relationship to growth inhibition of Candida albicans
. Infect Immun 60:4604–4611
PenkA.,
PittrowL.1999; Role of fluconazole in the long-term suppressive therapy of fungal infections in patients with artificial implants. Mycoses 42 (Suppl. 2):91–96
PfallerM. A.,
JonesR. N.,
MesserS. A.,
EdmondM. B.,
WenzelR. P.1998; National surveillance of nosocomial blood stream infection due to Candida albicans : frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 31:327–332[CrossRef]
ReidG.,
DenstedtJ. D.,
KangY. S.,
LamD.,
NauseC.1992; Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J Urol 148:1592–1594
RietschelE. T.,
SchadeU.,
JensenM.,
WollenweberH. W.,
LuderitzO.,
GreismanS. G.1982; Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl 31:8–21
SamaranayakeL. P.,
MacFarlaneT. W.,
WilliamsonM. I.1987; Comparison of Sabouraud dextrose and Pagano–Levin agar media for detection and isolation of yeasts from oral samples. J Clin Microbiol 25:162–164
SamaranayakeL. P.,
LambA. B.,
LameyP. J.,
MacFarlaneT. W.1989; Oral carriage of Candida species and coliforms in patients with burning mouth syndrome. J Oral Pathol Med 18:233–235[CrossRef]
SedgleyC. M.,
SamaranayakeL. P.1994; The oral prevalence of aerobic and facultatively anaerobic Gram-negative rods and yeasts in Hong Kong Chinese. Arch Oral Biol 39:459–466[CrossRef]
TheinZ. M.,
SamaranayakeY. H.,
SamaranayakeL. P.2006; Effect of oral bacteria on growth and survival of Candida albicans biofilms. Arch Oral Biol 51:672–680[CrossRef]
WebbB. C.,
ThomasC. J.,
WillcoxM. D.,
HartyD. W.,
KnoxK. W.1998; Candida -associated denture stomatitis. Aetiology and management: a review. Part 2. Oral diseases caused by Candida species. Aust Dent J 43:160–166[CrossRef]